Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas

Overview of attention for article published in Genome Medicine, August 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 60,603 followers.

RT @DrBuiPathology: A3. #her2low There is emerging evidence showing it may be a distinct subtype of #breast #cancer. https://t.co/kiAgluu…

RT @DrBuiPathology: A3. #her2low There is emerging evidence showing it may be a distinct subtype of #breast #cancer. https://t.co/kiAgluu…

RT @DrBuiPathology: A3. #her2low There is emerging evidence showing it may be a distinct subtype of #breast #cancer. https://t.co/kiAgluu…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.